Intravenous pamidronate for refractory rheumatoid arthritis

BACKGROUND: Patients with rheumatoid arthritis may be resistant to conventional treatment with disease-modifying antirheumatic drugs (DMARDs). On the other hand, biologic therapy is costly and may be inconvenient for many patients. Pamidronate is a potent bisphosphonate with the capacity of modifyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Salesi, Mansour, Mottaghi, Peyman, Karimifar, Mansour, Farajzadegan, Ziba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634265/
https://www.ncbi.nlm.nih.gov/pubmed/23626604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634265/
https://www.ncbi.nlm.nih.gov/pubmed/23626604

Ejemplares similares